Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03926169 |
|---|---|
| Brief Title: | A Global Study Comparing Risankizumab to Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa (DETERMINED 1) |
| First Submitted : | April 23, 2019 |
| First Submitted that Met QC Criteria : | April 23, 2019 |
| First Posted : | April 24, 2019 |
| Results First Submitted : | July 14, 2022 |
| Results First Submitted that Met QC Criteria : | July 14, 2022 |
| Results First Posted : | August 11, 2022 |
| Certification/Extension First Submitted : | January 3, 2022 |
| Certification/Extension First Submitted that Met QC Criteria : | January 3, 2022 |
| Certification/Extension First Posted : | January 5, 2022 |
| Last Update Submitted that Met QC Criteria : | July 14, 2022 |
| Last Update Posted : | August 11, 2022 |